Pediatric Neurology
Volume 26, Issue 3 , Pages 201-204 , March 2002

Tandem mass spectrometry and newborn screening: pilot data and review

  • James J. Filiano, MD

      Affiliations

    • Corresponding Author InformationCommunications should be addressed to: Dr. Filiano; Department of Pediatrics; Dartmouth Hitchcock Medical Center; 1 Medical Center Drive; Lebanon, NH 03756, USA
    • Department of Pediatrics; Dartmouth Hitchcock Medical Center; Lebanon, New Hampshire, USA
  • ,
  • Sherry Gray Bellimer, BA

      Affiliations

    • Department of Pediatrics; Dartmouth Hitchcock Medical Center; Lebanon, New Hampshire, USA
  • ,
  • Pamela L. Kunz, MD

      Affiliations

    • Department of Pediatrics; Dartmouth Hitchcock Medical Center; Lebanon, New Hampshire, USA

Received 16 May 2001 ,Accepted 1 October 2001.

References 

  1. Hannon WH, Grosse SD. Using tandem mass spectrometry for metabolic disease screening among newborns. Morb Mortal Wkly Rep. 2001;50:1–22
  2. North KN, Korson MS, Gopal YR, et al.  Neonatal-onset propionic acidemia (Neurologic and developmental profiles, and implications for management). J Pediatr. 1995;126:916–922
  3. Waitzman NJ, Romano PS, Scheffler RM. Estimates of the economic costs of birth defects. Inquiry. 1994;31:188–205
  4. Yoon PW, Olney RS, Khoury MJ, Sappenfield WM, Chavez GF, Taylor D. Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study. Arch Pediatr Adolesc Med. 1997;151:1096–1103
  5. Lord J, Thomason MJ, Littlejohns P, et al.  Secondary analysis of economic data (A review of cost-benefit studies of neonatal screening for phenylketonuria). J Epidemiol Community Health. 1999;53:179–186
  6. Pollitt RJ, Green A, McCabe CJ, et al.  Neonatal screening for inborn errors of metabolism (Cost, yield and outcome). Health Technol Assess. 1997;1:1–202
  7. Seymore CA, Thomason MJ, Chalmers RA, et al.  Newborn screening for inborn errors of metabolism (A systematic review). Health Technol Assess. 1997;1:1–95
  8. Riis P. Ethical, legal and health economic aspects of neonatal screening. Acta Paediatr Suppl. 1999;88:96–98

PII: S0887-8994(01)00384-8

Pediatric Neurology
Volume 26, Issue 3 , Pages 201-204 , March 2002